Hemin Attenuates Cisplatin-Induced Acute Renal Injury in Male Rats

Oxidative Medicine and Cellular Longevity - Tập 2014 - Trang 1-9 - 2014
Mohamed A. Al‐Kahtani1, Ashraf M. Abdel‐Moneim1,2, Omar M. Elmenshawy1,3, Mohamed A. Elkersh4,5
1Department of Biological Sciences, Faculty of Science, King Faisal University, Al-Hassa 31982, Saudi Arabia
2Department of Zoology, Faculty of Science, Alexandria University, Alexandria, 21511, Egypt
3Department of Zoology, Faculty of Science, Al-Azhar University, Nasr City 11884, Egypt
4Department of Biochemistry, Faculty of Science, Alexandria University, Alexandria 21511, Egypt
5Department of Chemistry, Faculty of Science, King Faisal University, Al-Hassa 31982, Saudi Arabia

Tóm tắt

Background.The aim of this study is to investigate the protective effects of hemin (the heme oxygenase-1 [OH-1] inducer) against nephrotoxic effects induced by cisplatin [cis-diamminedichloroplatinum II (CP)] in male rats.Methods.The evaluation was performed through monitoring renal redox parameters: lipid peroxidation (LPO), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione reductase (GR), and reduced glutathione (GSH). The work also examined renal function tests (urea and creatinine), tissue proinflammatory mediator like nitric oxide (NO), and kidney cytopathology.Results.A single intraperitoneal dose of CP (10 mg/kg b.w.) caused significant elevation of blood urea, serum creatinine, and renal LPO and NO, along with significant decline of the activities of GPx and GR, but renal SOD activity and GSH level were statistically insignificant as compared to control group. Subcutaneous injection of hemin (40 µmol/kg b.w.) partially ameliorated CP-induced renal damage, based on suppression of blood urea, serum creatinine, the renal MDA and NO levels, and increased antioxidant capacity in CP-treated rats. The results of histopathological and ultrastructural investigations supported the renoprotective effect of hemin against CP-induced acute toxicity.Conclusion.The induction of HO-1 by hemin is a promising approach in the treatment of CP-induced nephrotoxicity. However, further preclinical studies are warranted to test effectiveness of CP/hemin on the outcome of tumor chemotherapy.

Từ khóa


Tài liệu tham khảo

10.1016/j.etp.2008.04.016

10.1016/j.fct.2010.05.004

10.1016/j.fct.2011.10.039

10.1016/j.cbi.2010.10.014

10.1006/phrs.1999.0600

10.1016/j.lfs.2004.11.005

10.1016/j.tox.2006.10.025

10.1097/MAJ.0b013e31812dfe1e

10.1016/j.tox.2007.12.007

10.1016/j.fct.2011.07.008

10.1016/j.fct.2013.09.003

10.1371/journal.pone.0086057

10.1016/j.fct.2006.01.013

10.1016/j.bbrc.2010.11.067

10.1016/S0378-4274(00)00222-8

10.1006/taap.2002.9409

10.1016/j.tox.2007.05.014

2008, Chinese Medical Journal, 121, 241, 10.1097/00029330-200802010-00012

10.1016/j.tox.2008.12.022

10.1016/j.etap.2008.11.002

10.4254/wjh.v5.i10.541

2012, Drug Discoveries & Therapeutics, 6, 147

10.1016/j.lfs.2007.11.014

1979, Clinical Chemistry, 25, 336, 10.1093/clinchem/25.2.336a

10.1016/0009-8981(71)90467-0

10.1016/0003-2697(79)90738-3

10.1152/ajplung.00076.2006

10.1016/j.niox.2006.01.002

1988, Clinical Chemistry, 34, 2164

10.1006/abio.1997.2273

10.1016/S0076-6879(85)13062-4

10.1124/dmd.105.005314

1951, The Journal of biological chemistry, 193, 265, 10.1016/S0021-9258(19)52451-6

10.3923/pjbs.2007.3497.3506

2014, Histology and Histopathology, 29, 45

10.3109/0886022X.2011.601832

10.3923/pjbs.2010.463.479

10.1097/01.ASN.0000128974.07460.34

10.1016/S0002-9440(10)65359-X

1988

10.1016/S0014-2999(02)02251-3

10.1016/j.tox.2006.11.073

10.1016/j.fct.2009.12.027

10.1155/2014/320513

10.1016/j.cbi.2013.06.016

10.1073/pnas.252626999

10.1152/ajprenal.90449.2008

10.2174/1389450111009011485

10.3164/jcbn.10-61

10.1073/pnas.081082098

10.1074/jbc.M100103200

1991, The FASEB Journal, 5, 2085, 10.1096/fasebj.5.7.1707021

10.1016/j.etp.2009.02.066

10.1016/j.toxlet.2007.10.006

10.1016/S0891-5849(00)00373-7

10.1152/physrev.00029.2006

10.3181/00379727-210-43927AA

1997, The American Journal of Physiology, 272, H2327

10.1111/j.1365-2249.2004.02594.x

10.1053/jhep.2003.50114

10.1016/j.juro.2007.01.015

10.1016/j.molimm.2007.10.011

10.1111/jphp.12067